Complications of Intrathecal Drug Delivery Systems

Published on 27/02/2015 by admin

Filed under Anesthesiology

Last modified 27/02/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1406 times

Chapter 5 Complications of Intrathecal Drug Delivery Systems

Complications of Needle Placement in the Intrathecal Space

Bleeding

During the placement of an intrathecal catheter, the needle typically passes through the epidural space with little trauma. However, in anticoagulated patients and in patients with bleeding dyscrasias, epidural bleeding and resultant epidural hematomas are a significant risk (Table 5-1). Epidural bleeding is likely common but usually goes unnoticed in the absence of postoperative imaging studies. Rarely, an epidural bleed may produce a clinically significant epidural hematoma. Untreated, an epidural hematoma can progress and result in numbness, weakness, increased pain, and ultimately paralysis. If the development of an epidural hematoma is suspected, the patient should undergo immediate magnetic resonance imaging (MRI) and surgical evaluation. Prompt hematoma evacuation should be performed within 12 hours of the onset of symptoms because evacuation within this time frame has been associated with better neurological outcomes. Any patient complaining of weakness in the postoperative period should undergo immediate evaluation for the presence of an epidural hematoma (Box 5-1).

Table 5-1 Commonly Used Drugs That May Result in Increased Risk of Bleeding Complications

Brand Name Generic
Angiomax Bivalirudin
Arixtra Fondaparinux
Jantoven Coumadin
Fragmin Dalteparin
Innohep Tinzaparin
Lovenox Enoxaparin
Argatroban Argatroban
ATryn Antithrombin
None Heparin
Iprivask Desirudin
Refludan Lepirudin
Thrombate Antithrombin
Pradaxa Dabigatran
Aggrenox Aspirin/dipyridamole
Effient Prasugrel
Plavix Clopidogrel
Pletal Cilostazol
ReoPro Abciximab
Ticlid Ticlopidine
Aggrastat Tirofiban
Agrylin Anagrelide
Integrilin Eptifibatide
Persantine Dipyridamole

Recommendations for Avoiding Bleeding-Associated Complications

Today physicians encounter many patients that are anticoagulated with medications such as antifibrinolytic and antiplatelet agents. Discontinuing antifibrinolytic medications for 7 to 10 days has previously been recommended, but there are no data to establish when it is safe to perform neuraxial procedures in patients treated with these medications.1 Additionally, there has never been a clear relationship established between aspirin and nonsteroidal administration and epidural hematoma formation. Most physicians do not require patients to discontinue low-dose aspirin and nonsteroidal antiinflammatory medications before undergoing implantation of an ITDD device. Recommendations published by the American Society of Regional Anesthesia and Pain Management attempt to provide guidelines for discontinuing anticoagulation in patients who are to undergo neuraxial procedures.1

Infection

Epidural abscess formation can result in compression of neurologic structures and symptoms similar to those of epidural hematoma formation. Although the risk of epidural abscess formation is probably less than one in 1000, any patient who complains of increasing pain at the catheter insertion site, develops a clinically significant fever over 101°F or greater, or complains of weakness or numbness should undergo urgent MRI with proper precautions and surgical evaluation if warranted. It is important for the physician to be aware that epidural abscess may initially present as pain around the catheter insertion point and may evolve to include severe radiating pain if the infection invades the neural foramen or compresses the spinal cord.

Discitis and meningitis are serious complications that must undergo immediate treatment if suspected. Superficial wound infections are much more common but still require prompt attention to prevent penetration of the deep tissue layers and involvement of the implant. It is recommended that an infectious disease consultation be obtained in any infection that is suspected of penetrating beyond the superficial layers. Prompt neurosurgical consultation is mandatory in any patient suspected of having an epidural abscess.

Risks factors for infection include any patient with a history of immunocompromised state such as HIV infection, history of methicillin-resistant Staphylococcus aureus infection, organ transplantation, cancer, diabetes mellitus, and skin infections at the time of implantation (Box 5-2). Transverse myelitis is uncommon but is seen with catheter infections and may not be present with known infection.2 Routine laboratory studies, including C-reactive protein (CRP), complete blood count (CBC) with differential, and erythrocyte sedimentation rate (ESR), should be obtained in patients with clinical symptoms of infection.